<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01006187</url>
  </required_header>
  <id_info>
    <org_study_id>1000014280</org_study_id>
    <nct_id>NCT01006187</nct_id>
  </id_info>
  <brief_title>Comparison of Different Methods for Reducing Pain From Influenza Vaccine Injections</brief_title>
  <official_title>Comparison of Different Analgesic Methods for Reducing Pain From Adult Intramuscular Influenza Virus Vaccine Injection</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The Hospital for Sick Children</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The Hospital for Sick Children</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to compare four different analgesic strategies in adults
      undergoing routine influenza immunization
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In this study, we will compare relative effectiveness of 4 analgesic strategies (i.e.,
      topical local anesthetics, vapocoolant spray, tactile stimulation and distraction) in adults
      undergoing routine immunization in order to provide further evidence of the effectiveness of
      each intervention and to determine if one method is superior to another. We are not including
      a 'no treatment' group because we do not wish to subject participants to unnecessary pain
      when there are available analgesic treatments. Moreover, in the presence of a 'no treatment'
      group, we cannot rule out a placebo effect for all treatment groups unless we provide a
      matched placebo for each intervention, which is not feasible. In future studies, we plan to
      address the added benefit of combining analgesic interventions (i.e., evaluating the effect
      of a multimodal approach).
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2009</start_date>
  <completion_date type="Actual">November 2009</completion_date>
  <primary_completion_date type="Actual">November 2009</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain from adult intramuscular influenza virus injection</measure>
    <time_frame>1 day</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Adverse Events</measure>
    <time_frame>1 day</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Anxiety</measure>
    <time_frame>1 hour</time_frame>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">352</enrollment>
  <condition>Pain</condition>
  <condition>Anxiety</condition>
  <arm_group>
    <arm_group_label>Group 1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>1 liposomal lidocaine 4% cream .</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Vapocoolant spray</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 3</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Rubbing adjacent to the injection site</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 4</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Distraction by means of self-selected reading material or internet</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Liposomal lidocaine</intervention_name>
    <description>4% cream; approximately one gram applied to injection site under an occlusive dressing for 20 minutes prior to injection</description>
    <arm_group_label>Group 1</arm_group_label>
    <other_name>Maxilene™</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Vapocoolant spray</intervention_name>
    <description>medium stream spray on arm for 4-10 seconds prior to injection</description>
    <arm_group_label>Group 2</arm_group_label>
    <other_name>PainEase™</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Rubbing adjacent to the injection site</intervention_name>
    <description>rubbing adjacent to the injection site before and during injection</description>
    <arm_group_label>Group 3</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Distraction</intervention_name>
    <description>By means of self-selected reading material or video</description>
    <arm_group_label>Group 4</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy adults aged &gt;18 years of age undergoing voluntary immunization with influenza
             virus vaccine

        Exclusion Criteria:

          -  Pre-medication with any of the analgesic interventions in this study,

          -  Chronic pain syndromes/conditions

          -  Receiving systemic analgesics and sedatives

          -  Abnormal circulation (e.g., Raynaud's phenomenon)

          -  Allergy/hypersensitivity to amide local anesthetics

          -  Allergy to influenza virus vaccine or constituents

          -  Prior participation in the trial

          -  Inability to understand the VAS

          -  If suspected to be pregnant, pregnant or breastfeeding (due to possible treatment with
             liposomal lidocaine).
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Anna Taddio, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Hospital for Sick Children</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>The Hospital for Sick Children</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>July 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 29, 2009</study_first_submitted>
  <study_first_submitted_qc>October 29, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 2, 2009</study_first_posted>
  <last_update_submitted>July 18, 2011</last_update_submitted>
  <last_update_submitted_qc>July 18, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 19, 2011</last_update_posted>
  <responsible_party>
    <name_title>Dr. Anna Taddio</name_title>
    <organization>The Hospital for Sick Children</organization>
  </responsible_party>
  <keyword>Analgesics</keyword>
  <keyword>Influenza</keyword>
  <keyword>Vapocoolant</keyword>
  <keyword>vaccination</keyword>
  <keyword>pain</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Influenza, Human</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lidocaine</mesh_term>
    <mesh_term>Analgesics</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

